Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome
Nathaniel W. York, … , Hongzhen Hu, Colin G. Nichols
Nathaniel W. York, … , Hongzhen Hu, Colin G. Nichols
Published November 10, 2020
Citation Information: JCI Insight. 2020;5(23):e141443. https://doi.org/10.1172/jci.insight.141443.
View: Text | PDF
Research Article Gastroenterology Muscle biology

Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome

  • Text
  • PDF
Abstract

Cantú syndrome (CS), caused by gain-of-function (GOF) mutations in pore-forming (Kir6.1, KCNJ8) and accessory (SUR2, ABCC9) ATP-sensitive potassium (KATP) channel subunit genes, is frequently accompanied by gastrointestinal (GI) dysmotility, and we describe 1 CS patient who required an implanted intestinal irrigation system for successful stooling. We used gene-modified mice to assess the underlying KATP channel subunits in gut smooth muscle and to model the consequences of altered KATP channels in CS gut. We show that Kir6.1/SUR2 subunits underlie smooth muscle KATP channels throughout the small intestine and colon. Knockin mice, carrying human KCNJ8 and ABCC9 CS mutations in the endogenous loci, exhibited reduced intrinsic contractility throughout the intestine, resulting in death when weaned onto solid food in the most severely affected animals. Death was avoided by weaning onto a liquid gel diet, implicating intestinal insufficiency and bowel impaction as the underlying cause, and GI transit was normalized by treatment with the KATP inhibitor glibenclamide. We thus define the molecular basis of intestinal KATP channel activity, the mechanism by which overactivity results in GI insufficiency, and a viable approach to therapy.

Authors

Nathaniel W. York, Helen Parker, Zili Xie, David Tyus, Maham Akbar Waheed, Zihan Yan, Dorothy K. Grange, Maria Sara Remedi, Sarah K. England, Hongzhen Hu, Colin G. Nichols

×

Figure 3

KATP GOF mutations in smooth muscle cause hyperpolarization and reduced basal contractility.

Options: View larger image (or click on image) Download as PowerPoint
KATP GOF mutations in smooth muscle cause hyperpolarization and reduced ...
(A) Representative records of basal tension in WT (black), SUR2AV/AV (red), and Kir6.1WT/VM (blue) ileal segments before (basal) and after application of glibenclamide (at arrow). (B) Tension in glibenclamide relative to basal, from experiments as in A. Significance was determined by 1-way ANOVA and post hoc Tukey’s test for pairwise comparison. WT duodenum, jejunum, ileum and colon; n = 6, 7, 7, and 4, respectively. SUR2AV/WT duodenum, jejunum, ileum, and colon; n = 5, 4, 7, and 8, respectively. SUR2AV/AV duodenum, jejunum, ileum, and colon; n = 4, 8, 8, and 9, respectively. Kir6.1WT/VM duodenum, jejunum, ileum, and colon; n = 5, 8, 11, and 6, respectively. (C) Representative recordings of electrical activity in WT, SUR2AV/AV, and Kir6.1WT/VM intestinal muscle segments, measured using impalement electrodes. (D) Slow wave amplitude measured from maximum hyperpolarized potential to maximum nonspiking plateau potential in WT, SUR2AV/AV, and Kir6.1WT/VM muscle from experiments as in A. (E) Resting membrane potential (maximum hyperpolarized potential) in WT, SUR2AV/AV, and Kir6.1WT/VM muscle. For D and E, n = 7 for WT, n = 4 for SUR2AV/AV, and n = for Kir6.1WT/VM. For each segment, significance was determined by 1-way ANOVA and post hoc Dunnett’s test, comparing each genotype with WT. Data are shown as mean ± SEM (*P < 0.05, ***P < 0.001).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts